Kidney Disease News and Research

RSS

Kidney Health Week, experts criticise government inaction

Kidney Health Week is being observed at Broken Hill Hospital this week by the Broken Hill Health Service. As a part of this the residents will receive complete kidney check ups including blood pressure and blood sugar and advice regarding kidney health.

26 May 2010

Genzyme's suit stays final FDA approval of Watson's generic Renvela ANDA

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market sevelamer carbonate 800mg tablets. Watson's sevelamer carbonate tablet is the generic version of Genzyme's Renvela®. Renvela ® is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who are on dialysis.

26 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.

25 May 2010

Cytochroma reports positive Phase 1/2 results for CTAP101 Capsules in non-dialysis CKD patients

Cytochroma today announced positive Phase 1/2 results for CTAP101 Capsules, a product being developed to treat secondary hyperparathyroidism (SHPT) associated with vitamin D insufficiency in non-dialysis chronic kidney disease (CKD) patients. The study demonstrated that a single dose of CTAP101 Capsules was safe, effective and well tolerated.

25 May 2010

Genzyme finalizes terms for consent decree regarding Allston manufacturing plant

Genzyme Corporation announced today that the terms for the consent decree regarding the Allston manufacturing plant have been finalized. These terms are in line with the company's expectations announced last month. The consent decree is subject to approval by the United States District Court for the District of Massachusetts.

25 May 2010

Transplant centers should utilize DCD kidneys to minimize patients’ mortality rates

In the United States over 80,000 people are on the kidney transplant waiting list, and thousands die each year waiting for transplants. For most dialysis patients, kidney transplantation increases their chances of survival.

21 May 2010

Compatibility between donated kidney's weight and weight of recipient improves success of transplantation

Receiving an organ low in weight in relation to the recipient's body weight increases kidney transplant recipients risk of complications and transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that compatibility between a donated kidney's weight and the weight of the recipient could improve the success of transplantation.

21 May 2010

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.

21 May 2010

Vitamin D plays much wider role in people's life

Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.

21 May 2010

Chronic kidney disease patients with depression have poorer health outcomes: Researchers

Patients with chronic kidney disease who have been diagnosed with depression are twice as likely to be hospitalized, progress to long-term dialysis treatments or die within a year as those who are not depressed, UT Southwestern Medical Center researchers have found.

20 May 2010

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.

18 May 2010

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

Common tests of kidney function and damage predict the risk of death from cardiovascular diseases and all causes, according to a paper from the Chronic Kidney Disease Prognosis Consortium, established last year by Kidney Disease: Improving Global Outcomes.

18 May 2010

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

18 May 2010

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.

17 May 2010

Better health care for the indigenous population

A report from Melbourne University says that Indigenous Australians are six times more likely than other Australians to be blind and more than a third of this population has never had an eye examination. Now a substantial number of optometrists will be sent to remote Aboriginal communities under a $6.5 million federal program.

16 May 2010

Do Something World Festival wraps up week-long campaign of volunteer service

California Pastor Miles McPherson returned to the Caribbean this week with a large team of volunteers to "do something" for the region. McPherson, a former NFL Player, Senior Pastor of the Rock Church, San Diego and founder of Miles Ahead has produced the Cayman Islands "Do Something World Festival," to take place May 14-15.

15 May 2010

Medco Health Solutions donates $125,000 to U.S. Red Cross for Tennessee flood relief efforts

Medco Health Solutions, Inc.,, on behalf of its affiliated companies and the Medco Foundation, has donated $125,000 to the U.S. Red Cross for relief efforts targeted at victims of recent flooding in Tennessee and other affected areas.

15 May 2010

Hospira's I.V. administration set product line to be standardized to non-DEHP

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, will expand its commitment to non-DEHP products by transitioning customers to its portfolio of non-DEHP intravenous administration sets.

15 May 2010

Elie Hirschfeld gifts $50,000 to help Roosevelt Hospital's ED Expansion and Redesign Project

A new commitment of $50,000 from Elie Hirschfeld, President and Chief Executive Officer of Hirschfeld Properties and a Trustee of Continuum Health Partners, will help further underwrite Roosevelt Hospital's Emergency Department Expansion and Redesign Project. His gifts to the initiative, to date, total over $150,000.

15 May 2010

Kidney Disease News and Research

Kidney Health Week, experts criticise government inaction

Genzyme's suit stays final FDA approval of Watson's generic Renvela ANDA

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Cytochroma reports positive Phase 1/2 results for CTAP101 Capsules in non-dialysis CKD patients

Genzyme finalizes terms for consent decree regarding Allston manufacturing plant

Transplant centers should utilize DCD kidneys to minimize patients’ mortality rates

Compatibility between donated kidney's weight and weight of recipient improves success of transplantation

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

Vitamin D plays much wider role in people's life

Chronic kidney disease patients with depression have poorer health outcomes: Researchers

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Better health care for the indigenous population

Do Something World Festival wraps up week-long campaign of volunteer service

Medco Health Solutions donates $125,000 to U.S. Red Cross for Tennessee flood relief efforts

Hospira's I.V. administration set product line to be standardized to non-DEHP

Elie Hirschfeld gifts $50,000 to help Roosevelt Hospital's ED Expansion and Redesign Project

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News